Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Drug and Alcohol Dependence|December 27, 2014
Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information CentreLaura Hondebrink, Johanna J Nugteren-van Lonkhuyzen, Daan Van Der Gouwe, et al.Regulatory Toxicology and Pharmacology : RTP|March 24, 2012
Risk assessment of gamma-hydroxybutyric acid (GHB) in the NetherlandsJan G C van Amsterdam, Margriet van Laar, Tibor M Brunt, et al.Neuroscience and Biobehavioral Reviews|February 21, 2012
Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdoseJan G C van Amsterdam, Tibor M Brunt, Minni T B McMaster, et al.Addiction (Abingdon, England)|May 6, 2009
An analysis of cocaine powder in the Netherlands: content and health hazards due to adulterantsTibor M Brunt, Sander Rigter, Jani Hoek, et al.Addiction (Abingdon, England)|October 7, 2009
Content of ecstasy in the Netherlands: 1993-2008Neeltje Vogels, Tibor M Brunt, Sander Rigter, et al.Current Neuropharmacology|June 21, 2021
Cognitive Impairment Following Clinical or Recreational Use of Gammahydroxybutyric Acid (GHB): A Systematic ReviewJan Van Amsterdam, Tibor M Brunt, Filipa R Pereira, et al.Drug Testing and Analysis|February 19, 2016
Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) projectTibor M Brunt, Constanze Nagy, Alexander Bücheli, et al.Drug and Alcohol Dependence|November 5, 2015
Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofuransJohanna J Nugteren-van Lonkhuyzen, Antoinette J H P van Riel, Tibor M Brunt, et al.Drug and Alcohol Dependence|January 22, 2013
Sociodemographic and substance use characteristics of γ hydroxybutyrate (GHB) dependent inpatients and associations with dependence severityTibor M Brunt, Maarten W Koeter, Nina Hertoghs, et al.Journal of Clinical Psychopharmacology|April 22, 2014
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabisTibor M Brunt, Marianne van Genugten, Kathrin Höner-Snoeken, et al.Pageof 4